nach oben

Erschienen in:

06.05.2014 | Zertifizierte Fortbildung

Gang- und Gleichgewichtsstörungen bei Morbus Parkinson

Motorische Erkrankungen

verfasst von: Dr. med. Florin Gandor, PD Dr. med. Georg Ebersbach

Erschienen in: NeuroTransmitter | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Gangstörungen gehören zu den charakteristischen Merkmalen der idiopathischen Parkinson-Erkrankung und stellen oft ein Initialsymptom dar. Sie sind vor allem in der Langzeitbehandlung des Parkinson-Syndroms eine Herausforderung. Da herkömmliche Behandlungsstrategien meist keine ausreichende Kontrolle axialer Symptome bewirken, sind neue Therapieansätze erforderlich.

Ebersbach G, Heijmenberg M, Kindermann L, Trottenberg T, Wissel J, Poewe W (1999) Interference of rhythmic constraint on gait in healthy subjects and patients with early Parkinson’s disease: evidence for impaired locomotor pattern generation in early Parkinson’s disease. Mov Disord 14:619–25PubMedCrossRef

Ebersbach G, Sojer M, Valldeoriola F, Wissel J, Müller J, Tolosa E, Poewe W (1999) Comparative analysis of gait in Parkinson’s disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain 122 (Pt 7):1349–55PubMedCrossRef

Morris ME, Iansek R, Matyas TA, Summers JJ (1994) The pathogenesis of gait hypokinesia in Parkinson’s disease. Brain 117 (Pt 5):1169–81PubMedCrossRef

Morris ME, Iansek R, Matyas TA, Summers JJ (1996) Stride length regulation in Parkinson’s disease. Normalization strategies and underlying mechanisms. Brain 119 (Pt 2):551–68PubMedCrossRef

Baltadjieva R, Giladi N, Gruendlinger L, Peretz C, Hausdorff JM (2006) Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson’s disease. Eur J Neurosci 24:1815–20PubMedCrossRef

Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL (1998) Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson’s disease and Huntington’s disease. Mov Disord 13:428–37PubMedCrossRef

Cantiniaux S, Vaugoyeau M, Robert D, Horrelou-Pitek C, Mancini J, Witjas T, Azulay J-P (2010) Comparative analysis of gait and speech in Parkinson’s disease: hypokinetic or dysrhythmic disorders? J Neurol Neurosurg Psychiatry 81:177–84PubMedCrossRef

Rochester L, Burn DJ, Woods G, Godwin J, Nieuwboer A (2009) Does auditory rhythmical cueing improve gait in people with Parkinson’s disease and cognitive impairment? A feasibility study. Mov Disord 24:839–45PubMedCrossRef

Hely MA, Morris JGL, Reid WGJ, Trafficante R (2005) Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 20:190–9PubMedCrossRef

10.

Kempster PA, Williams DR, Selikhova M, Holton J, Revesz T, Lees AJ (2007) Patterns of levodopa response in Parkinson’s disease: a clinico-pathological study. Brain 130:2123–8PubMedCrossRef

11.

Müller MLTM, Frey K a, Petrou M, Kotagal V, Koeppe R a, Albin RL, Bohnen NI (2013) β-Amyloid and postural instability and gait difficulty in Parkinson’s disease at risk for dementia. Mov Disord 28:296–301PubMedCentralPubMedCrossRef

12.

Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A (2011) Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol 10:734–44PubMedCrossRef

13.

Giladi N, McDermott MP, Fahn S, Przedborski S, Jankovic J, Stern M, Tanner C (2001) Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 56:1712–21PubMedCrossRef

14.

Gray P, Hildebrand K (2000) Fall risk factors in Parkinson’s disease. J Neurosci Nurs 32:222–8PubMedCrossRef

15.

Ashburn A, Stack E, Pickering RM WC (2001) edicting fallers in a community-based sample of people with Parkinson’s disease. Gerontology 47:277–81PubMedCrossRef

16.

Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH (2001) Prospective assessment of falls in Parkinson’s disease. J Neurol 248:950–8PubMedCrossRef

17.

Wood BH, Bilclough JA, Bowron A, Walker RW (2002) Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 72:721–5PubMedCentralPubMedCrossRef

18.

Bloem BR, Hausdorff JM, Visser JE, Giladi N (2004) Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena. Mov Disord 19:871–84PubMedCrossRef

19.

Mak M, Pang M (2010) Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features. J Neurol 257:1543–51PubMedCrossRef

20.

Giladi N, Kao R, Fahn S (1997) Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 12:302–5PubMedCrossRef

21.

Giladi N, Hausdorff JM (2006) The role of mental function in the pathogenesis of freezing of gait in Parkinson’s disease. J Neurol Sci 248:173–6PubMedCrossRef

22.

Amboni M, Cozzolino A, Longo K, Picillo M, Barone P (2008) Freezing of gait and executive functions in patients with Parkinson’s disease. Mov Disord 23:395–400PubMedCrossRef

23.

Naismith SL, Shine JM, Lewis SJG (2010) The specific contributions of set-shifting to freezing of gait in Parkinson’s disease. Mov Disord 25:1000–4PubMedCrossRef

24.

Kostic VS, Agosta F, Pievani M, Stefanova E, Jecmenica-Lukic M, Scarale A, Spica V, Filippi M (2012) Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology 78:409–16PubMedCrossRef

25.

Hallett M (2008) The intrinsic and extrinsic aspects of freezing of gait. Mov Disord 23 Suppl 2:S439–43PubMedCrossRef

26.

Rochester L, Hetherington V, Jones D, Nieuwboer A, Willems A-M, Kwakkel G, Van Wegen E (2004) Attending to the task: interference effects of functional tasks on walking in Parkinson’s disease and the roles of cognition, depression, fatigue, and balance. Arch Phys Med Rehabil 85:1578–85PubMedCrossRef

27.

Abdo WF, Borm GF, Munneke M, Verbeek MM, Esselink RAJ, Bloem BR (2006) Ten steps to identify atypical parkinsonism. J Neurol Neurosurg Psychiatry 77:1367–9PubMedCentralPubMedCrossRef

28.

Cole MW, Schneider W (2007) The cognitive control network: Integrated cortical regions with dissociable functions. Neuroimage 37:343–60PubMedCrossRef

29.

Shine JM, Matar E, Ward PB, Bolitho SJ, Pearson M, Naismith SL, Lewis SJG (2013) Differential neural activation patterns in patients with Parkinson’s disease and freezing of gait in response to concurrent cognitive and motor load. PLoS One 8:e52602PubMedCentralPubMedCrossRef

30.

Snijders AH, Leunissen I, Bakker M, Overeem S, Helmich RC, Bloem BR, Toni I (2011) Gait-related cerebral alterations in patients with Parkinson’s disease with freezing of gait. Brain 134:59–72PubMedCrossRef

31.

Jahn K, Deutschländer A, Stephan T, Kalla R, Wiesmann M, Strupp M, Brandt T (2008) Imaging human supraspinal locomotor centers in brainstem and cerebellum. Neuroimage 39:786–92PubMedCrossRef

32.

La Fougère C, Zwergal A, Rominger A, Förster S, Fesl G, Dieterich M, Brandt T, Strupp M, Bartenstein P, Jahn K (2010) Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison. Neuroimage 50:1589–98PubMedCrossRef

33.

Zwergal A, la Fougère C, Lorenzl S, et al (2013) Functional disturbance of the locomotor network in progressive supranuclear palsy. Neurology 80:634–41PubMedCrossRef

34.

Tessitore A, Amboni M, Cirillo G, et al (2012) Regional gray matter atrophy in patients with Parkinson disease and freezing of gait. AJNR Am J Neuroradiol 33:1804–9PubMedCrossRef

35.

Almeida QJ, Lebold CA (2010) Freezing of gait in Parkinson’s disease: a perceptual cause for a motor impairment? J Neurol Neurosurg Psychiatry 81:513–8PubMedCrossRef

36.

Cohen RG, Chao A, Nutt JG, Horak FB (2011) Freezing of gait is associated with a mismatch between motor imagery and motor execution in narrow doorways, not with failure to judge doorway passability. Neuropsychologia 49:3981–8PubMedCentralPubMedCrossRef

37.

Snijders AH, Warrenburg BP Van De, Giladi N, Bloem BR (2007) Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 6:63–74PubMedCrossRef

38.

Ebersbach G, Sojer M, Müller J, Ransmayr G, Wenning G, Poewe W (2002) [Dysequilibrium in idiopathic Parkinson disease. The effect of cerebrovascular comorbidity]. Nervenarzt 73:162–5PubMedCrossRef

39.

Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, Litvan I (1999) Progression of falls in postmortemconfirmed parkinsonian disorders. Mov Disord 14:947–50PubMedCrossRef

40.

Fahn S (2005) Does levodopa slow or hasten the rate of progression of Parkinson’s disease? J Neurol 252 Suppl:IV37–IV42PubMedCrossRef

41.

Espay AJ, Fasano A, van Nuenen BFL, Payne MM, Snijders AH, Bloem BR (2012) “On” state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication. Neurology 78:454–7PubMedCentralPubMedCrossRef

42.

Nutt JG, Carter JH, Sexton GJ (2004) The dopamine transporter: importance in Parkinson’s disease. Ann Neurol 55:766–73PubMedCrossRef

43.

Moreau C, Delval A, Defebvre L, et al (2012) Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol 11:589–96PubMedCrossRef

44.

Auriel E, Hausdorff JM, Giladi N (2009) Methylphenidate for the treatment of Parkinson disease and other neurological disorders. Clin Neuropharmacol 32:75–81PubMedCrossRef

45.

Pollak L, Dobronevsky Y, Prohorov T, Bahunker S, Rabey JM (2007) Low dose methylphenidate improves freezing in advanced Parkinson’ s disease during off-state. J Neural Transm 145–148

46.

Devos D, Krystkowiak P, Clement F, et al (2007) Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson’s disease. J Neurosurg Psychiatry 78:470–5CrossRef

47.

Espay AJ, Dwivedi AK, Payne M, et al (2011) Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial. Neurology 76:1256–62PubMedCentralPubMedCrossRef

48.

Nutt JG, Carter JH, Carlson NE (2007) Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial. Arch Neurol 64:319–23PubMedCrossRef

49.

Moreau C, Delval A, Tiffreau V, et al (2012) Memantine for axial signs in Parkinson’s disease: a randomised, double-blind, placebocontrolled pilot study. J Neurol Neurosurg Psychiatry. doi: 10.1136/jnnp-2012-303182

50.

Chung KA, Lobb BM, Nutt JG, Horak FB (2010) Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 75:1263–9PubMedCentralPubMedCrossRef

51.

Deuschl G, Schade-Brittinger C, Krack P, et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908PubMedCrossRef

52.

Zibetti M, Merola A, Rizzi L, et al (2011) Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease. Mov Disord 26:2327–34PubMedCrossRef

53.

Schuepbach WMM, Rau J, Knudsen K, et al (2013) Neurostimulation for Parkinson’s Disease with Early Motor Complications. N Engl J Med 368:610–622PubMedCrossRef

54.

Moreau C, Defebvre L, Destée a, Bleuse S, Clement F, Blatt JL, Krystkowiak P, Devos D (2008) STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 71:80–4PubMedCrossRef

55.

Niu L, Ji L-Y, Li J-M, Zhao D-S, Huang G, Liu W-P, Qu Y, Ma L-T, Ji X-T (2012) Effect of bilateral deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson’s disease. J Int Med Res 40:1108–13PubMedCrossRef

56.

Rodriguez-Oroz MC, Obeso JA, Lang AE, et al (2005) Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 128:2240–9PubMedCrossRef

57.

Muniz AMS, Nadal J, Lyons KE, Pahwa R, Liu W (2012) Long-term evaluation of gait initiation in six Parkinson’s disease patients with bilateral subthalamic stimulation. Gait Posture 35:452–7PubMedCrossRef

58.

Hilliard JD, Frysinger RC, Elias WJ (2011) Effective subthalamic nucleus deep brain stimulation sites may differ for tremor, bradykinesia and gait disturbances in Parkinson’s disease. Stereotact Funct Neurosurg 89:357–64PubMedCrossRef

59.

Xie T, Kang UJ, Warnke P (2012) Effect of stimulation frequency on immediate freezing of gait in newly activated STN DBS in Parkinson’s disease. J Neurol Neurosurg Psychiatry 83:1015–7PubMedCrossRef

60.

Nieuwboer A, Kwakkel G, Rochester L, Jones D, van Wegen E, Willems AM, Chavret F, Hetherington V, Baker K, Lim I (2007) Cueing training in the home improves gait-related mobility in Parkinson’s disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 78:134–40PubMedCentralPubMedCrossRef

61.

Jöbges M, Heuschkel G, Pretzel C, Illhardt C, Renner C, Hummelsheim H (2004) Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:1682–7PubMedCentralPubMedCrossRef

62.

Ebersbach G, Ebersbach A, Edler D, Kaufhold O, Kusch M, Kupsch A, Wissel J (2010) Comparing exercise in Parkinson’s disease—the Berlin LSVT®BIG study. Mov Disord 25:1902–8PubMedCrossRef

63.

Goodwin VA, Richards SH, Henley W, Ewings P, Taylor AH, Campbell JL (2011) An exercise intervention to prevent falls in people with Parkinson’s disease: a pragmatic randomised controlled trial. J Neurol Neurosurg Psychiatry 82:1232–8PubMedCrossRef

64.

Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, Maddalozzo G, Batya SS (2012) Tai chi and postural stability in patients with Parkinson’s disease. N Engl J Med 366:511–9PubMedCentralPubMedCrossRef

65.

Fukada K, Endo T, Yokoe M, Hamasaki T, Hazama T, Sakoda S (2013) L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson’s disease. Med Hypotheses 80:209–12PubMedCrossRef

66.

Mazzone P, Lozano A, Stanzione P, Galati S, Scarnati E, Peppe A, Stefani A (2005) Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson’s disease. Neuroreport 16:1877–1881PubMedCrossRef

67.

Plaha P, Gill SS (2005) Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson’s disease. Neuroreport 16:1883–1887PubMedCrossRef

68.

Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, Pierantozzi M, Brusa L, Scarnati E, Mazzone P (2007) Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain 130:1596–607PubMedCrossRef

69.

Ferraye MU, Debû B, Fraix V, et al (2010) Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson’s disease. Brain 133:205–14PubMedCrossRef

70.

Weiss D, Walach M, Meisner C, et al (2013) Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial. Brain 136:2098–108PubMedCentralPubMedCrossRef

71.

Fisher BE, Wu AD, Salem GJ, Song J, Lin C-HJ, Yip J, Cen S, Gordon J, Jakowec M, Petzinger G (2008) The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson’s disease. Arch Phys Med Rehabil 89:1221–9PubMedCentralPubMedCrossRef

72.

Hirsch MA, Farley BG (2009) Exercise and neuroplasticity in persons living with Parkinson’s disease. Eur J Phys Rehabil Med 45:215–29PubMed

73.

Petzinger GM, Fisher BE, Van Leeuwen J-E, Vukovic M, Akopian G, Meshul CK, Holschneider DP, Nacca A, Walsh JP, Jakowec MW (2010) Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson’s disease. Mov Disord 25 Suppl 1:S141–5PubMedCrossRef

74.

Kleim JA, Jones TA, Schallert T (2003) Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res 28:1757–69PubMedCrossRef

75.

Kleim JA, Jones TA (2008) Principles of experience- dependent neural plasticity: implications for rehabilitation after brain damage. J Speech Lang Hear Res 51:S225–39PubMedCrossRef

Titel: Gang- und Gleichgewichtsstörungen bei Morbus Parkinson
Motorische Erkrankungen
verfasst von: Dr. med. Florin Gandor
PD Dr. med. Georg Ebersbach
Publikationsdatum: 06.05.2014
Verlag: Urban & Vogel
Erschienen in: NeuroTransmitter / Ausgabe 5/2014
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI: https://doi.org/10.1007/s15016-014-0004-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Gang- und Gleichgewichtsstörungen bei Morbus Parkinson

Motorische Erkrankungen

Zusammenfassung

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Fatigue in Neurologie und Psychiatrie

ADHS – Alternative zu MPH

Depression – das bin doch nicht ICH!

Hydromorphon einmal täglich jetzt auch generisch

PTBS nach Foltererfahrung in einem Kriegsgebiet

Wieviel kosten uns Alkohol- und Nikotinabusus wirklich?

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie